Cellatoz Therapeutics, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cellatozrx.com
The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Cellatoz Therapeutics, Inc
- Target Recruit Count
- 9
- Registration Number
- NCT05947578
- Locations
- 🇰🇷
Samsung Medical center, Seoul, Gangnam-gu, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath